Compared with untreated flu, oseltamivir treatment reduced the risk of serious neuropsychiatric events in children. Prescribing information for oseltamivir carries warnings about abnormal behavior in ...
Arcutis Biotherapeutics (ARQT) has just dosed the first participant in its Phase 1a/1b trial of ARQ-234, a CD200 receptor targeting fusion protein for atopic dermatitis, marking a fresh pipeline ...
Tampa Free Press on MSN
Medicine’s dirty little secret: New law demands to know exactly where your pills are made
Legislation to pull back the curtain on the global origins of America’s medicine cabinet gained significant momentum today as the CLEAR LABELS Act secured support in both the U.S. Senate and the House ...
In early 2026, the U.S. Supreme Court (the “Court”) agreed to hear a case at the heart of pharmaceutical intellectual property that could have significant implications for the manufacturers of both ...
A “black box” warning is the highest safety alert that the U.S. Food and Drug Administration requires drug manufacturers to include on medications in which clinical data shows the drug can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results